Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-09

Clinical Trial Update: Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to ergometrin for prevention of postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • ergometrin (ergometrin)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Postpartum Hemorrhage | Phase 4 | Status: UNKNOWN